Stay updated on Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.5.5 is now shown, replacing the previous v3.5.4. This indicates a minor update to the page content or structure without altering the underlying study information.
    Difference
    0.1%
    Check dated 2026-06-08T04:13:17.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now displays a new revision tag 'Revision: v3.5.4', replacing the previous 'Revision: v3.5.3'. This reflects a minor version update to the page rather than any substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-17T09:34:37.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s displayed revision/version marker was incremented from v3.5.2 to v3.5.3, reflecting a site release/update rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-25T18:53:49.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:44:24.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Footer and policy updates were added, including release notes, privacy and accessibility information, and government links.
    Difference
    100%
    Check dated 2026-03-28T03:46:30.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer/navigation items and several archived study documents were removed. The essential trial data remains accessible on the page.
    Difference
    22%
    Check dated 2026-03-21T01:17:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CC-486 in Platinum-resistant Ovarian Cancer Clinical Trial page.